ONC Insider Holders & Insider Ownership

List of insiders holdings for BeOne Medicines Ltd.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	BAKER BROS. ADVISORS LP 14159 L.P. Baker Bros. Advisors (GP) LLC BAKER JULIAN BAKER FELIX 667 L.P. Baker Brothers Life Sciences LP Director 10% Owner	2024-12-10 21:30:34	125,276,610 0	125,276,610	Form 13D
2	HHLR ADVISORS LTD. HILLHOUSE INVESTMENT MANAGEMENT LTD. 10% Owner	2025-05-13 16:15:10	68,551,141 0	68,551,141	Form 13D
3	OYLER JOHN Chief Executive Officer	2025-07-11 17:14:15	7,812,333 46,055,316	53,867,649	Form 4
4	CB Biotech Investment Ltd CPEChina Fund L.P. CITIC PE Associates L.P. CITIC PE Funds Ltd 10% Owner	2016-02-09 20:07:35	19,601,138 0	19,601,138	Form 4
5	AMGEN INC 10% Owner	2021-09-13 19:27:07	18,943,802 0	18,943,802	Form 4
6	Wang Xiaodong Chair, Scientific Advisory Brd	2025-06-25 17:08:08	5,154,770 4,978,213	10,132,983	Form 4
7	BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director	2025-05-22 16:10:06	20,838 9,038,122	9,058,960	Form 4
8	Glazer Donald W. Director	2024-06-07 16:58:01	2,752,615 0	2,752,615	Form 4
9	Li Ji EVP and Gl. Head of Bus. Dev.	2018-03-02 18:41:22	2,721,000 0	2,721,000	Form 4
10	Wu Xiaobin President and COO	2025-08-15 16:40:17	2,618,329 4,000	2,622,329	Form 4
11	Peterson Amy C. CMO, Immuno-oncology	2018-12-19 18:34:10	1,966,402 0	1,966,402	Form 4
12	Wang Lai Global Head of R&D	2025-07-31 17:05:32	1,023,529 666,965	1,690,494	Form 4
13	Liang Howard CFO & Chief Strategy Officer	2021-06-30 16:45:49	1,553,149 0	1,553,149	Form 4
14	Yan Wendy Xiaojun Sr. VP, Head of Reg. Affairs	2016-07-15 16:30:50	825,000 0	825,000	Form 4
15	Yang Jianxin Sr. VP, Head of Clinical Dev.	2016-07-15 16:34:25	825,000 0	825,000	Form 4
16	Lee Chan Henry SVP, General Counsel	2025-08-15 16:38:46	518,752 0	518,752	Form 4
17	Wang Julia Aijun Chief Financial Officer	2024-07-03 17:05:32	426,595 0	426,595	Form 4
18	Huang Jane CMO, Hematology	2021-12-16 17:50:15	371,331 0	371,331	Form 4
19	Rosenberg Aaron Chief Financial Officer	2025-08-05 17:16:07	215,332 0	215,332	Form 4
20	Tang Ke Director	2017-04-21 16:42:20	199,992 0	199,992	Form 4
21	Yuan RuiRong Chief Medical Officer	2016-02-09 20:08:35	130,000 0	130,000	Form 4
22	Malley Thomas Director	2023-06-20 19:00:29	103,671 0	103,671	Form 4
23	HOOPER ANTHONY C Director	2025-05-22 19:41:43	87,490 0	87,490	Form 4
24	Sanders Corazon (Corsee) D. Director	2025-05-22 19:42:58	79,976 0	79,976	Form 4
25	Dugan Margaret Director	2025-05-22 19:44:07	79,690 0	79,690	Form 4
26	Riva Alessandro Director	2025-05-22 19:44:55	79,690 0	79,690	Form 4
27	Yi Qingqing Director	2025-06-12 16:19:09	56,940 0	56,940	Form 4
28	BRANDICOURT OLIVIER Director	2025-05-22 19:46:02	50,076 0	50,076	Form 4
29	Sharp Shalini Director	2025-05-22 19:47:00	41,886 0	41,886	Form 4
30	su Jingshyh S Director	2021-06-21 16:34:12	25,298 0	25,298	Form 4
31	Chen Timothy Yung-Cheng Director	2021-06-21 16:42:08	25,298 0	25,298	Form 4
32	GOLLER MICHAEL Director	2016-02-02 19:40:27	0 0	0	Form 3
33	Ball Titus B. Principal Accounting Officer	2025-06-12 17:51:28	0 0	0	Form 4
34	Merck & Co. Inc. Merck Sharp & Dohme Corp. Merck Sharp & Dohme Research GmbH 10% Owner	2018-02-13 16:29:07	0 0	0	Form 13G
35	KRISHANA RANJEEV Director	2016-02-02 19:14:15	0 0	0	Form 3

Insider Holders & Insider Ownership - BeOne Medicines Ltd. (ONC)